ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.650,03
-1,38%
S&P 500
5.307,01
-0,27%
US Dollar vs BRL
5,1535
0,02%
Bitcoin
69.643,85
0,78%
Brent Oil
81,73
0,25%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Anchiano Therapeutics Ltd (ANCN)

  7. Anchiano Therapeutics Ltd (ANCN) Notícias

ANCN

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANCN
DataHoraFonteTítuloCódigoCompanhia
16/06/202317:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
19/05/202317:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
11/05/202307:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202308:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/11/202208:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/11/202218:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/08/202217:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANCNAnchiano Therapeutics Ltd
31/05/202211:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
28/04/202217:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/04/202217:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ANCNAnchiano Therapeutics Ltd
03/09/202117:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/05/202107:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/04/202107:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202118:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202117:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ANCNAnchiano Therapeutics Ltd
30/03/202108:49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202117:07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202109:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/03/202118:54GlobeNewswire Inc.Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private FinancingNASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202118:28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202115:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANCNAnchiano Therapeutics Ltd
10/02/202115:20Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
13/01/202111:32Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/12/202011:00GlobeNewswire Inc.Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger AgreementNASDAQ:ANCNAnchiano Therapeutics Ltd
21/11/201919:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/11/201908:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
24/04/201918:22Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/03/201917:18Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ANCNAnchiano Therapeutics Ltd
14/03/201909:16GlobeNewswire Inc.Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock ExchangeNASDAQ:ANCNAnchiano Therapeutics Ltd
13/02/201911:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ANCNAnchiano Therapeutics Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANCN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
UNIP6
UNIPAR PNB
BOV
IRBR3
IRB BRASIL ON
BOV
AMER3
Americanas ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados